Use of Hydralazine‐Isosorbide Dinitrate Combination in African American and Other Race/Ethnic Group Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction

BACKGROUND: Hydralazine‐isosorbide dinitrate (H‐ISDN) therapy is recommended for African American patients with moderate to severe heart failure with reduced ejection fraction (<40%) (HFrEF), but use, temporal trends, and clinical characteristics associated with H‐ISDN therapy in clinical practic...

Descripción completa

Detalles Bibliográficos
Autores principales: Golwala, Harsh B., Thadani, Udho, Liang, Li, Stavrakis, Stavros, Butler, Javed, Yancy, Clyde W., Bhatt, Deepak L., Hernandez, Adrian F., Fonarow, Gregg C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828812/
https://www.ncbi.nlm.nih.gov/pubmed/23966379
http://dx.doi.org/10.1161/JAHA.113.000214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828812/
https://www.ncbi.nlm.nih.gov/pubmed/23966379
http://dx.doi.org/10.1161/JAHA.113.000214

Ejemplares similares